Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Lynn RosenbergJulie R Palmer

Abstract

Oral contraceptive formulations have changed over time, making it relevant to assess the effect of more recent formulations on breast cancer risk. In addition, some studies have found stronger positive associations of oral contraceptive use with estrogen receptor-negative (ER(-)) than with ER-positive (ER(+)) breast cancer. We carried out the first assessment of the effect of oral contraceptive use on the incidence of breast cancer classified by receptor status among African American women, a group disproportionately affected by ER(-) cancer. We followed 53,848 Black Women's Health Study participants from 1995 to 2007 through biennial health questionnaires, in which participants reported information about incident breast cancer, oral contraceptive use, and breast cancer risk factors. Pathology information was obtained on receptor status for 789 incident cases. Incidence rate ratios (IRR) with 95% confidence intervals (95% CI) were derived from Cox regression models with control for confounding factors. Ever use of oral contraceptives was more strongly associated with ER(-)PR(-) breast cancer (279 cases; IRR, 1.65; 95% CI, 1.19-2.30) than with ER(+)PR(+) cancer (386 cases; IRR, 1.11; 95% CI, 0.86-1.42). The risk of ER(-)PR(-) br...Continue Reading

References

Dec 15, 1992·American Journal of Epidemiology·R M Mayberry, C Stoddard-Wright
Jan 1, 1991·American Journal of Public Health·B B GerstmanB V Stadel
Jun 1, 1987·International Journal of Epidemiology·J M Piper, D L Kennedy
Feb 1, 1987·American Journal of Epidemiology·J L StanfordR N Hoover
Nov 14, 1997·International Journal of Cancer. Journal International Du Cancer·L A BrintonJ B Schoenberg
Aug 30, 2000·Journal of the National Cancer Institute. Monographs·R B Dickson, G M Stancel
Oct 27, 2001·Breast Cancer Research and Treatment·H FurbergJ Geradts
Jun 27, 2002·Breast Cancer Research and Treatment·Sue A Joslyn
Jun 28, 2002·The New England Journal of Medicine·Polly A MarchbanksLinda K Weiss
May 17, 2003·Cancer Causes & Control : CCC·Michelle D AlthuisLouise A Brinton
Oct 10, 2003·The New England Journal of Medicine·Diana B Petitti
Feb 5, 2004·Journal of the National Cancer Institute·Graham A ColditzSusan E Hankinson
Dec 24, 2004·American Journal of Epidemiology·Ingrid J HallBeth Newman
Mar 17, 2005·Journal of the National Cancer Institute·Rowan T ChlebowskiRoss Prentice
Mar 3, 2007·Cancer Research·Piyush B GuptaCharlotte Kuperwasser
Mar 6, 2007·American Journal of Epidemiology·Sumitra ShantakumarMarilie D Gammon
Jun 21, 2007·Breast Cancer Research and Treatment·Robert C MillikanCharles M Perou
Jul 28, 2007·International Journal of Cancer. Journal International Du Cancer·Carol SweeneyMartha L Slattery
Sep 15, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie R PalmerLynn Rosenberg
Dec 17, 2008·American Journal of Epidemiology·Lynn RosenbergJulie R Palmer
Apr 2, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica M DolleKathleen E Malone
Oct 6, 2009·Critical Reviews in Oncology/hematology·Carol A PariseVincent Caggiano

❮ Previous
Next ❯

Citations

Mar 5, 2013·Breast Cancer Research and Treatment·Adana A LlanosPeter G Shields
Oct 3, 2013·Cancer Causes & Control : CCC·Lynn RosenbergJulie R Palmer
Nov 23, 2012·American Journal of Epidemiology·Julie R PalmerLynn Rosenberg
Nov 9, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie R PalmerLynn Rosenberg
Dec 18, 2013·Cancer Causes & Control : CCC·Julie R PalmerAndrew F Olshan
Oct 16, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Hang ZhuYang Wang
Oct 16, 2015·Breast Cancer Research and Treatment·Stephen A HaddadJulie R Palmer
May 28, 2013·Asia-Pacific Journal of Public Health·Thunyarat AnothaisintaweeAmmarin Thakkinstian
Jan 20, 2018·International Journal of Cancer. Journal International Du Cancer·Marit BusundEiliv Lund
Sep 4, 2017·Environmental Health : a Global Access Science Source·Janet M GrayJeanne Rizzo
Apr 30, 2019·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Anne GompelUNKNOWN European Society of Contraception Expert Group on Hormonal Contraception
Feb 19, 2017·Breast Cancer Research and Treatment·Carol A Parise, Vincent Caggiano
Aug 29, 2017·International Journal of Cancer. Journal International Du Cancer·Kimberly A BertrandJulie R Palmer
Apr 9, 2013·Race and Social Problems·Karen Benjamin Guzzo, Sarah R Hayford
Mar 19, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Elisabeth F BeaberChristopher I Li
Aug 12, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lynn RosenbergLucile L Adams-Campbell
Sep 10, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer M GierischEvan R Myers
Oct 26, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kimberly A BertrandJulie R Palmer
Sep 7, 2021·International Journal of Cancer. Journal International Du Cancer·Danja SarinkMelissa A Merritt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
William F AndersonPhilip S Rosenberg
The Medical Clinics of North America
M I Goran
The Journal of Steroid Biochemistry and Molecular Biology
H AdlercreutzT Hase
Journal of the National Cancer Institute
M S WolffN Dubin
© 2021 Meta ULC. All rights reserved